Those large AH price moves for BMY and PFE are not crazy insofar as Eliquis has the potential to be a very big-selling drug. The drop in Bayer’s share price today seems a bit excessive, however.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.